Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$588M |
| 2 |
UnitedHealth
UNH
|
+$429M |
| 3 |
Johnson & Johnson
JNJ
|
+$333M |
| 4 |
Amazon
AMZN
|
+$229M |
| 5 |
Microsoft
MSFT
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EXE
Expand Energy Corp
EXE
|
+$322M |
| 2 |
JPMorgan Chase
JPM
|
+$304M |
| 3 |
K
Kellanova
K
|
+$164M |
| 4 |
SUM
Summit Materials, Inc. Class A Common Stock
SUM
|
+$159M |
| 5 |
AZPN
Aspen Technology Inc
AZPN
|
+$156M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.81% |
| 2 | Financials | 18.7% |
| 3 | Industrials | 12.07% |
| 4 | Healthcare | 10.44% |
| 5 | Consumer Discretionary | 10.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3276
Pyxis Oncology
PYXS
$168M
| $35.8K | ﹤0.01% |
36,516
-74,535
| -67% | -$99.4K |
|
3277
Aprea Therapeutics
APRE
$7.68M
| $34K | ﹤0.01% |
16,655
-409
| -2% | -$1.28K |
|
|
TMQ
3278
Trilogy Metals
TMQ
$541M
| $33.6K | ﹤0.01% |
21,693
| – | – |
|
3279
DNA X Inc
SONM
$5.05M
| $33.6K | ﹤0.01% |
873
-22
| -2% | -$1.05K |
|
|
AIFU
3280
AIFU Inc
AIFU
$206M
| $33.5K | ﹤0.01% |
398
-742
| -65% | -$122K |
|
3281
Milestone Pharmaceuticals
MIST
$138M
| $31.7K | ﹤0.01% |
39,450
| – | – |
|
|
SBDS
3282
DELISTED
Solo Brands Inc
SBDS
| $31.3K | ﹤0.01% |
4,645
-5,624
| -55% | -$172K |
|
|
VXRT
3283
DELISTED
Vaxart
VXRT
| $30.7K | ﹤0.01% |
75,491
| – | – |
|
|
HOOK
3284
DELISTED
HOOKIPA Pharma
HOOK
| $30.7K | ﹤0.01% |
28,431
-20,204
| -42% | -$33.3K |
|
3285
Immunic
IMUX
$190M
| $30K | ﹤0.01% |
2,752
| – | – |
|
3286
Educational Development Corp
EDUC
$11.8M
| $29.3K | ﹤0.01% |
21,398
-1,355
| -6% | -$2.03K |
|
|
CMBM
3287
DELISTED
Cambium Networks
CMBM
| $28.7K | ﹤0.01% |
40,695
-13,472
| -25% | -$13.2K |
|
3288
Battalion Oil
BATL
$31.9M
| $28.3K | ﹤0.01% |
21,769
-1,791
| -8% | -$2.87K |
|
|
LGO
3289
Largo
LGO
$59.8M
| $27.2K | ﹤0.01% |
16,872
| – | – |
|
3290
Arts-Way Manufacturing Co
ARTW
$11.2M
| $26.7K | ﹤0.01% |
16,797
| – | – |
|
3291
Energy Vault
NRGV
$517M
| $26.7K | ﹤0.01% |
38,334
+4,697
| +14% | +$7.22K |
|
3292
PharmaCyte Biotech
PMCB
$6.18M
| $25.4K | ﹤0.01% |
20,299
-6,542
| -24% | -$10.6K |
|
3293
Beam Global
BEEM
$23.3M
| $25.2K | ﹤0.01% |
12,376
| – | – |
|
|
CARV
3294
DELISTED
Carver Bancorp
CARV
| $24.5K | ﹤0.01% |
17,408
| – | – |
|
3295
Sidus Space
SIDU
$171M
| $24.5K | ﹤0.01% |
+16,579
| New | +$37.9K |
|
3296
Babcock & Wilcox
BW
$1.39B
| $23.4K | ﹤0.01% |
34,739
| – | – |
|
|
FLNT
3297
Fluent
FLNT
$102M
| $23.1K | ﹤0.01% |
+10,581
| New | +$27.9K |
|
3298
PDS Biotechnology
PDSB
$38.4M
| $21.9K | ﹤0.01% |
18,382
-8
| -0% | -$11 |
|
3299
Great Elm Group
GEG
$67.4M
| $21.6K | ﹤0.01% |
11,419
| – | – |
|
|
IGMS
3300
DELISTED
IGM Biosciences
IGMS
| $21.2K | ﹤0.01% |
18,376
-228
| -1% | -$424 |
|
Similar funds
Dimensional Fund Advisors's Q1 2025 Portfolio in Review
As of Q1 2025, Dimensional Fund Advisors held 3,398 positions worth $402B, down 3.4% from $416B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q1 2025: portfolio turnover was 4%. Dimensional Fund Advisors opened 59 new positions and exited 78, leaving the 3,398-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q1 2025 buy was Sandisk: 849,963 shares worth $40.5M.
- Dimensional Fund Advisors added most to Apple in Q1 2025, an estimated $588M increase.
- Dimensional Fund Advisors's biggest Q1 2025 reduction was Expand Energy Corp, cutting an estimated $322M.
- Dimensional Fund Advisors fully exited Summit Materials, Inc. Class A Common Stock in Q1 2025, selling an estimated $159M.
- Dimensional Fund Advisors's ten largest holdings make up 15% of its $402B portfolio in Q1 2025.
- Dimensional Fund Advisors opened 59 new positions and closed 78 in Q1 2025.
- Dimensional Fund Advisors's portfolio value fell 3.4% quarter-over-quarter to $402B.
Based on Dimensional Fund Advisors's 13F filing for Q1 2025, filed 13 May 2025.